MALIGNANT CONNECTIVE TISSUE NEOPLASM

This adverse event was reported 22 times

These drugs are most commonly taken by patients reporting MALIGNANT CONNECTIVE TISSUE NEOPLASM:

# Drug Count
0 PAZOPANIB HYDROCHLORIDE 10
1 IFOSFAMIDE 2
2 APIXABAN 1
3 ASPIRIN 1
4 ASPIRIN 325 MG 1
5 ASPIRIN 81 MG 1
6 BEVACIZUMAB 1
7 BRIGATINIB 1
8 CARBAMAZEPINE 1
9 DACARBAZINE 1
See all common drugs associated with MALIGNANT CONNECTIVE TISSUE NEOPLASM

MALIGNANT CONNECTIVE TISSUE NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ENTRECTINIB 1 0.0006
1 PAZOPANIB HYDROCHLORIDE 10 0.0004
2 BRIGATINIB 1 0.0003
3 DACARBAZINE 1 0.0001
4 MESNA INJECTION 1 0.0001
5 MESNA 1 0.0001
6 DALTEPARIN SODIUM 1 0.0001
7 REGORAFENIB 1 0.0001
8 VALSARTAN AND HYDROCHLOROTHIAZIDE 1 0.0001
9 TEMOZOLOMIDE 1 0.0000
See all drugs enriched for association with MALIGNANT CONNECTIVE TISSUE NEOPLASM

MALIGNANT CONNECTIVE TISSUE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 1 0.0000
1 BCL-2 Inhibitor [EPC] 1 0.0000
2 Alkylating Drug [EPC] 2 0.0000
3 Microtubule Inhibitor [EPC] 1 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
5 Thiazide Diuretic [EPC] 1 0.0000
6 Mood Stabilizer [EPC] 1 0.0000
7 Factor Xa Inhibitor [EPC] 1 0.0000
8 Kinase Inhibitor [EPC] 2 0.0000
9 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
See all drug classes enriched for association with MALIGNANT CONNECTIVE TISSUE NEOPLASM